Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY8SW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,054
Award facts
- Contract value 100% obligated
- $34,053.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,053.95 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's federal contract awards demonstrate its capability to efficiently fulfill government procurement requirements for essential pharmaceutical products, with delivery orders ranging from small-value transactions to substantial orders exceeding $45,000. As a subsidiary of Cencora, Inc., AmerisourceBergen leverages its parent organization's significant IDC to provide comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FY8SW?
SPE2DR26FY8SW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FY8SW worth?
The government has obligated $34,054 on SPE2DR26FY8SW.
Is contract SPE2DR26FY8SW an order under another contract?
Yes. SPE2DR26FY8SW is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8SW competed?
The extent of competition for SPE2DR26FY8SW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award